INDIVUTEST
DEAD

Serial Number

88651520

Owner

IndivuTest GmbH

Attorney

R. Glenn Schroeder

Filing Date

Oct 11, 2019

Add to watchlist:

No watchlists yet
View on USPTO

INDIVUTEST Trademark

Serial Number: 88651520

INDIVUTEST is a trademark filed by IndivuTest GmbH on October 11, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

IndivuTest GmbH (3 trademarks)

Falkenried 88
Hamburg 20251 , DE

Entity Type: 11

Trademark Details

Filing Date

October 11, 2019

Registration Date

Not Registered

Published for Opposition

September 22, 2020

Goods & Services

Scientific apparatus and instruments, namely, tissue punches, punch biopsy, biopsy needles, apparatus for collecting biological samples such as tissue, cuts, blood, serum, plasma, ascites, cerebrospinal fluid, urine or stool; electronic apparatus and instruments for scientific laboratory research, namely, electronic analyzers and analyzers for the qualitative and quantitative recognition of samples and identification of the sample type; scientific electronic apparatus for the typing of tissue and tissue samples and tissue cuts; apparatus for recording, transmission or reproduction of data, magnetic data carriers, data processing equipment and computers

Pharmaceutical and veterinary preparations, in particular medicines for human beings and animals, namely, pharmaceutical and veterinary preparations for the treatment of cancer, metabolic diseases, cardiovascular diseases, inflammatory diseases, diseases of the immune system; human and animal sample material, namely, allograft or xenograft tissue preparations, tissue cuts, blood plasma, blood serum, ascites, cerebrospinal fluid, human and animal urine and human and animal stool; test kits for human and animal sample material, namely, allograft or xenograft tissue preparations, tissue cuts, blood plasma, blood serum, ascites, cerebrospinal fluid, human and animal urine and human and animal stool; diagnostic and therapeutic preparations, in particular made by using molecular biological, molecular genetic, genetic engineering, immunological and biotechnical methods for clinical and medical and laboratory use

Medical analyses in connection with the treatment of individuals including X-rays and blood samples, namely, medical testing for diagnostic and treatment purposes; medical clinic services; pharmaceutical advisory services; medical diagnostic testing, monitoring and reporting services

Scientific research; design and development of new technology for others in the field of cancer, metabolic diseases, cardiovascular diseases, inflammatory diseases, diseases of the immune system; industrial analysis and research services; design and development of computer hardware and software, in particular computer programs; scientific research for medical purposes, in particular molecular biological, immunological and histological laboratory services, in particular research and development in the field of human medical and veterinary medical diagnostics and therapy; scientific research for medical purposes and in the field of genetic engineering in the nature of typing of tissue and tissue samples and cuts by means of molecular biological, immunological, and histological methods; diagnostic services in the medical field for scientific research services purposes; diagnostic services in the field of cancer for scientific research services purposes; diagnostic services for scientific research services purposes related to the generation of complex data and data sets obtained by multi-omics analysis of human and animal samples, namely, tissue samples, tissue preparations, tissue cuts, blood plasma, blood serum, ascites, cerebrospinal fluid, human and animal urine and human and animal stool, and provision of such data and data sets in whole or in part, unprocessed or processed, to patients, scientists, physicians, medical institutions or scientific institutions; generation of complex data and data sets by multi-omics analysis of human and animal sample material, namely, tissue samples, tissue preparations, tissue cuts, blood plasma, blood serum, ascites, cerebrospinal fluid, human and animal urine and human and animal stool; diagnostic services related to generated and/or analysed complex data and data sets received through multi-omics analysis of human and animal sample material, namely, tissue samples, tissue preparations, tissue cuts, blood plasma, blood serum, ascites, cerebrospinal fluid, human and animal urine and human and animal stool

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Dec 18, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 18, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 28, 2023 EXRA
SOU EXTENSION 5 GRANTED
Apr 27, 2023 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 27, 2023 AITU
SOU EXTENSION 5 FILED
Apr 21, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Apr 21, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 16, 2022 EXRA
SOU EXTENSION 4 GRANTED
Nov 14, 2022 EX4G
SOU EXTENSION 4 FILED
Nov 14, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Nov 14, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 13, 2022 EXRA
SOU EXTENSION 3 GRANTED
May 11, 2022 EX3G
SOU EXTENSION 3 FILED
May 11, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
May 11, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 2, 2021 EXRA
SOU EXTENSION 2 GRANTED
Oct 29, 2021 EX2G
SOU EXTENSION 2 FILED
Oct 29, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 29, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 8, 2021 EXRA
SOU EXTENSION 1 GRANTED
May 6, 2021 EX1G
SOU EXTENSION 1 FILED
May 6, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
May 6, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 17, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 22, 2020 NPUB
PUBLISHED FOR OPPOSITION
Sep 22, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 2, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 19, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 4, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 3, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 3, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 18, 2020 GNRN
NON-FINAL ACTION E-MAILED
Feb 18, 2020 GNRT
NON-FINAL ACTION WRITTEN
Feb 18, 2020 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Feb 3, 2020 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jan 28, 2020 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 16, 2020 CNSA
ASSIGNED TO EXAMINER
Jan 16, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 17, 2019 NWOS
NEW APPLICATION ENTERED
Oct 15, 2019 NWAP